[144] GLOBE LIFE INC. SEC Filing

Rhea-AI Filing Summary

Form 144 filed for Globe Life Inc. (GL) reports an intended sale of 4,500 shares of common stock through APEX CLEARING on the NYSE with an aggregate market value of $641,205 and an approximate sale date of 09/12/2025. The shares were acquired by the seller from Globe Life via stock option exercises on 02/28/2019 (2,100 shares) and 02/24/2021 (2,400 shares); the payment source for the sale is listed as proceeds of stock option exercise. The filing also discloses a sale on 09/10/2025 of 4,974 shares generating gross proceeds of $695,532.32. The filer attests not to possess undisclosed material adverse information.

Positive

• Clear disclosure of the number of shares (4,500) and aggregate market value ($641,205) for the proposed sale
• Source of shares explicitly identified as stock option exercises dated 02/28/2019 and 02/24/2021 (2,100 and 2,400 shares respectively)
• Recent sale disclosed showing 4,974 shares sold on 09/10/2025 for gross proceeds of $695,532.32, providing transaction transparency

Negative

• None.

Insights

Securities Analyst

TL;DR: Insider preparing modest sale of vested option shares; recent near-term sale also reported.

The filing documents the proposed sale of 4,500 common shares acquired through prior option exercises, with proceeds designated as coming from those exercises. A separate sale of 4,974 shares on 09/10/2025 produced $695,532.32 in gross proceeds. These disclosures are routine Section 144 notifications by an affiliate or insider selling vested equity. The data suggest the transactions relate to option liquidity rather than issuance events or capital raises, and provide clear, transaction-level transparency for market participants.

Corporate Governance Expert

TL;DR: Routine insider disclosure; no governance red flags apparent in the notice.

The Form 144 conveys that the shares to be sold were obtained via stock option exercises in 2019 and 2021 and that the seller has signed the attestation about material nonpublic information. There is no indication in this form of unusual governance actions, related-party transactions, or undisclosed compensatory arrangements. The filing fulfills regulatory notice requirements for proposed insider sales under Rule 144.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	APEX CLEARING 350 N ST. PAUL ST SUITE 300 Dalls TX 75070	4500	641205	80436773	09/12/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/28/2019	Stock Option Exercise	GLOBE LIFE INC.			2100	09/12/2025	Proceeds of Stock Option Exercise
Common	02/24/2021	Stock Option Exercise	GLOBE LIFE INC.			2400	09/12/2025	Proceeds of Stock Option Exercise

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Dolores Skarjune 3700 South Stonebridge Drive McKinney TX 75070	Common	09/10/2025	4974	695532.32

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Globe Life (GL) Form 144 disclose about the proposed sale?

The Form 144 discloses a proposed sale of 4,500 common shares on the NYSE with an aggregate market value of $641,205 and an approximate sale date of 09/12/2025.

How were the shares being sold acquired according to the filing?

The shares were acquired via stock option exercises: 2,100 shares on 02/28/2019 and 2,400 shares on 02/24/2021.

Did the filer sell any Globe Life (GL) shares recently?

Yes. The form reports a sale on 09/10/2025 of 4,974 shares that generated $695,532.32 in gross proceeds.

Through which broker will the proposed sale be executed?

The proposed sale is to be executed through APEX CLEARING (350 N St. Paul St, Suite 300, Dallas, TX) on the NYSE.

What does the filer assert about material nonpublic information?

By signing the notice, the person represents that they do not know any material adverse information about the issuer that has not been publicly disclosed.